Diadema Partners LP Sc Pharmaceuticals Inc. Transaction History
Diadema Partners LP
- $328 Billion
- Q2 2025
A detailed history of Diadema Partners LP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Diadema Partners LP holds 217,623 shares of SCPH stock, worth $1.23 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
217,623Holding current value
$1.23 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
101Shares Held
36.5MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$21.9 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$20.1 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...